SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Volkmann J)
 

Search: WFRF:(Volkmann J) > (2015-2019) > Viewpoint and pract...

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease

Odin, Per (author)
Lund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Restorative Parkinson Unit,Forskargrupper vid Lunds universitet,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups,Central Hospital Bremerhaven
Chaudhuri, K. R. (author)
King's College London
Volkmann, J. (author)
University Hospital of Wϋrzburg
show more...
Antonini, A. (author)
University of Padova
Storch, A. (author)
University of Rostock
Dietrichs, E. (author)
University of Oslo
Pirtosek, Z. (author)
University Medical Centre Ljubljana
Henriksen, T. (author)
Copenhagen University Hospital
Horne, M. (author)
University of Melbourne
Devos, D. (author)
Bergquist, Filip, 1970 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för farmakologi,Institute of Neuroscience and Physiology, Department of Pharmacology,Sahlgrenska Academy
show less...
 (creator_code:org_t)
2018-05-10
2018
English.
In: Npj Parkinson's Disease. - : Springer Science and Business Media LLC. - 2373-8057. ; 4
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Motor aspects of Parkinson's disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of "wearable" technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson's disease (PD) is defining cutoff values that separate "controlled" from "uncontrolled" symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

quality-of-life
medication adherence
motor fluctuations
care
outcomes
impact
costs
trial
complications
dyskinesias
Neurosciences & Neurology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view